These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The effects of RANK blockade and osteoclast depletion in a model of pure osteoblastic prostate cancer metastasis in bone. Whang PG; Schwarz EM; Gamradt SC; Dougall WC; Lieberman JR J Orthop Res; 2005 Nov; 23(6):1475-83. PubMed ID: 16005175 [TBL] [Abstract][Full Text] [Related]
10. RANK-Fc: a therapeutic antagonist for RANK-L in myeloma. Sordillo EM; Pearse RN Cancer; 2003 Feb; 97(3 Suppl):802-12. PubMed ID: 12548579 [TBL] [Abstract][Full Text] [Related]
11. Quantitative small-animal surrogate to evaluate drug efficacy in preventing wear debris-induced osteolysis. Schwarz EM; Benz EB; Lu AP; Goater JJ; Mollano AV; Rosier RN; Puzas JE; Okeefe RJ J Orthop Res; 2000 Nov; 18(6):849-55. PubMed ID: 11192243 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta affects osteoclast differentiation via direct and indirect actions. Quinn JM; Itoh K; Udagawa N; Hausler K; Yasuda H; Shima N; Mizuno A; Higashio K; Takahashi N; Suda T; Martin TJ; Gillespie MT J Bone Miner Res; 2001 Oct; 16(10):1787-94. PubMed ID: 11585342 [TBL] [Abstract][Full Text] [Related]
13. Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis. Lubberts E; Oppers-Walgreen B; Pettit AR; Van Den Bersselaar L; Joosten LA; Goldring SR; Gravallese EM; Van Den Berg WB Arthritis Rheum; 2002 Nov; 46(11):3055-64. PubMed ID: 12428250 [TBL] [Abstract][Full Text] [Related]
14. Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. Zhang J; Dai J; Yao Z; Lu Y; Dougall W; Keller ET Cancer Res; 2003 Nov; 63(22):7883-90. PubMed ID: 14633717 [TBL] [Abstract][Full Text] [Related]
15. Regulation of osteoclastogenesis by gap junction communication. Matemba SF; Lie A; Ransjö M J Cell Biochem; 2006 Oct; 99(2):528-37. PubMed ID: 16639710 [TBL] [Abstract][Full Text] [Related]
16. Adeno-associated virus-mediated osteoprotegerin gene transfer protects against particulate polyethylene-induced osteolysis in a murine model. Yang SY; Mayton L; Wu B; Goater JJ; Schwarz EM; Wooley PH Arthritis Rheum; 2002 Sep; 46(9):2514-23. PubMed ID: 12355500 [TBL] [Abstract][Full Text] [Related]
18. Phenotypic and molecular studies of giant-cell tumors of bone and soft tissue. Lau YS; Sabokbar A; Gibbons CL; Giele H; Athanasou N Hum Pathol; 2005 Sep; 36(9):945-54. PubMed ID: 16153456 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of etanercept for wear debris-induced osteolysis. Childs LM; Goater JJ; O'Keefe RJ; Schwarz EM J Bone Miner Res; 2001 Feb; 16(2):338-47. PubMed ID: 11204434 [TBL] [Abstract][Full Text] [Related]
20. Osteocalcin fragment in bone matrix enhances osteoclast maturation at a late stage of osteoclast differentiation. Ishida M; Amano S J Bone Miner Metab; 2004; 22(5):415-29. PubMed ID: 15316862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]